Candriam S.C.A. - Q3 2017 holdings

$5.72 Billion is the total value of Candriam S.C.A.'s 723 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .

 Value Shares↓ Weighting
 INTEL CORPsdcv 2.950%12/1$6,375,000
+9.4%
4,4540.0%0.11%
+1.8%
 NUANCE COMMUNICATIONS INCnote 2.750%11/0$6,086,000
+0.6%
6,0000.0%0.11%
-7.0%
TTEK  TETRA TECH INC NEW$5,958,000
+1.7%
128,0000.0%0.10%
-5.5%
 HOLOGIC INCfrnt 12/1$5,024,000
-4.1%
4,1500.0%0.09%
-10.2%
IMGN  IMMUNOGEN INC$4,361,000
+7.6%
570,0000.0%0.08%0.0%
 ARES CAP CORPnote 4.750% 1/1$4,065,000
-2.0%
4,0000.0%0.07%
-9.0%
LXRX  LEXICON PHARMACEUTICALS INC$3,601,000
-25.3%
293,0000.0%0.06%
-30.8%
GHDX  GENOMIC HEALTH INC$3,177,000
-1.4%
99,0000.0%0.06%
-8.2%
 ROVI CORPnote 0.500% 3/0$3,205,000
+0.9%
3,2000.0%0.06%
-6.7%
RARE  ULTRAGENYX PHARMACEUTICAL IN$3,196,000
-14.2%
60,0000.0%0.06%
-20.0%
PKI  PERKINELMER INC$2,897,000
+1.2%
42,0000.0%0.05%
-5.6%
ODP  OFFICE DEPOT INC$2,809,000
-19.5%
618,7210.0%0.05%
-25.8%
TGTX  TG THERAPEUTICS INC$2,607,000
+17.9%
220,0000.0%0.05%
+9.5%
CHRS  COHERUS BIOSCIENCES INC$2,577,000
-7.0%
193,0000.0%0.04%
-13.5%
CMS  CMS ENERGY CORP$2,144,000
+0.1%
46,2920.0%0.04%
-7.5%
ALRN  AILERON THERAPEUTICS INC$2,007,000
+20.0%
150,0000.0%0.04%
+12.9%
PCRX  PACIRA PHARMACEUTICALS INC$1,990,000
-21.3%
53,0000.0%0.04%
-27.1%
 SPIRIT RLTY CAP INC NEWnote 2.875% 5/1$2,026,000
+1.7%
2,0000.0%0.04%
-5.4%
DVA  DAVITA INC$1,663,000
-8.3%
28,0000.0%0.03%
-14.7%
ALDR  ALDER BIOPHARMACEUTICALS INC$1,433,000
+6.9%
117,0000.0%0.02%0.0%
STAA  STAAR SURGICAL CO$1,407,000
+15.3%
113,0000.0%0.02%
+8.7%
CPRX  CATALYST PHARMACEUTICALS INC$1,411,000
-8.7%
560,0000.0%0.02%
-13.8%
REPH  RECRO PHARMA INC$1,347,000
+27.7%
150,0000.0%0.02%
+20.0%
WCN  WASTE CONNECTIONS INC$1,328,000
+8.6%
18,9840.0%0.02%0.0%
MKL  MARKEL CORP$1,213,000
+9.4%
1,1360.0%0.02%0.0%
AVDL  AVADEL PHARMACEUTICALS PLCsponsored adr$1,166,000
-4.7%
111,0000.0%0.02%
-13.0%
LPL  LG DISPLAY CO LTDspons adr rep$1,074,000
-16.5%
80,0000.0%0.02%
-20.8%
EMN  EASTMAN CHEM CO$1,116,000
+7.7%
12,3290.0%0.02%0.0%
FRT  FEDERAL REALTY INVT TRsh ben int new$1,074,000
-1.7%
8,6480.0%0.02%
-9.5%
TAP  MOLSON COORS BREWING COcl b$1,045,000
-5.5%
12,8040.0%0.02%
-14.3%
ELGX  ENDOLOGIX INC$981,000
-8.2%
220,0000.0%0.02%
-15.0%
COG  CABOT OIL & GAS CORP$908,000
+6.6%
33,9600.0%0.02%0.0%
MLM  MARTIN MARIETTA MATLS INC$915,000
-7.4%
4,4380.0%0.02%
-15.8%
FLT  FLEETCOR TECHNOLOGIES INC$844,000
+7.2%
5,4540.0%0.02%0.0%
VTVT  VTV THERAPEUTICS INCcl a$837,000
+20.3%
140,0000.0%0.02%
+15.4%
FNF  FIDELITY NATIONAL FINANCIAL$819,000
+5.8%
17,2580.0%0.01%
-6.7%
ADS  ALLIANCE DATA SYSTEMS CORP$797,000
-13.7%
3,5960.0%0.01%
-17.6%
RDHL  REDHILL BIOPHARMA LTDsponsored ads$770,000
+24.4%
71,2670.0%0.01%
+8.3%
AUPH  AURINIA PHARMACEUTICALS INC$740,000
+2.4%
118,0000.0%0.01%
-7.1%
LB  L BRANDS INC$741,000
-22.7%
17,8020.0%0.01%
-27.8%
PHM  PULTE GROUP INC$726,000
+11.5%
26,5520.0%0.01%
+8.3%
CAJ  CANON INCsponsored adr$700,000
+0.9%
20,4000.0%0.01%
-7.7%
HRL  HORMEL FOODS CORP$612,000
-5.7%
19,0340.0%0.01%
-8.3%
TWTR  TWITTER INC$605,000
-5.6%
35,8870.0%0.01%
-8.3%
ATO  ATMOS ENERGY CORP$578,000
+1.0%
6,8960.0%0.01%
-9.1%
 TRILLIUM THERAPEUTICS INC$559,000
+17.4%
110,0000.0%0.01%
+11.1%
AYI  ACUITY BRANDS INC$561,000
-15.8%
3,2780.0%0.01%
-23.1%
CMG  CHIPOTLE MEXICAN GRILL INC$511,000
-25.9%
1,6590.0%0.01%
-30.8%
LW  LAMB WESTON HLDGS INC$512,000
+6.4%
10,9270.0%0.01%0.0%
EVHC  ENVISION HEALTHCARE CORP$405,000
-28.2%
9,0010.0%0.01%
-36.4%
SLG  SL GREEN RLTY CORP$275,000
-4.2%
2,7120.0%0.01%0.0%
ETFC  E TRADE FINANCIAL CORP$259,000
+14.6%
5,9360.0%0.01%
+25.0%
DISCA  DISCOVERY COMMUNICATNS NEW$293,000
-17.5%
13,7450.0%0.01%
-28.6%
NI  NISOURCE INC$227,000
+0.9%
8,8760.0%0.00%0.0%
TSN  TYSON FOODS INCcl a$247,000
+12.8%
3,5000.0%0.00%0.0%
PTI  PROTEOSTASIS THERAPEUTICS IN$158,000
-55.0%
75,0000.0%0.00%
-57.1%
GORO  GOLD RESOURCE CORP$37,000
-9.8%
10,0000.0%0.00%0.0%
SDRL  SEADRILL LIMITED$5,0000.0%13,1000.0%0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP36Q3 20235.9%
GILEAD SCIENCES INC36Q3 20233.1%
MERCK & CO INC NEW36Q3 20232.6%
REGENERON PHARMACEUTICALS36Q3 20232.0%
JOHNSON & JOHNSON36Q3 20232.5%
BIOGEN INC36Q3 20232.6%
PROCTER & GAMBLE CO36Q3 20231.9%
VERTEX PHARMACEUTICALS INC36Q3 20232.1%
META PLATFORMS INC36Q3 20231.6%
VISA INC36Q3 20231.2%

View Candriam S.C.A.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-06
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-10
13F-HR2022-08-03
13F-HR2022-05-13
13F-HR2022-02-10

View Candriam S.C.A.'s complete filings history.

Compare quarters

Export Candriam S.C.A.'s holdings